MARÍA GABRIELA
RODRÍGUEZ MACÍAS
Investigadora Predoctoral
GlaxoSmithKline (United Kingdom)
Londres, Reino UnidoPublicaciones en colaboración con investigadores/as de GlaxoSmithKline (United Kingdom) (1)
2019
-
Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in adults with haematological malignancies: a phase 3, randomised, clinical trial and post-hoc efficacy analysis
The Lancet Infectious Diseases, Vol. 19, Núm. 9, pp. 988-1000